Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
We see an increase in the number of people with colds and flu during the holiday season, as people get together more with others. Antibiotics are very important ...
MELBOURNE, Australia, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Small Cap ...
Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...
Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...
Low morale' and 'overcrowding' found at Merseyside A&E but 'staff doing their best' C.difficile is a bacteria that can cause diarrhoea and often affects people taking antibiotics. Common symptoms ...
The new rapid point-of-care test named FebriDx uses a finger-prick blood sample to determine whether a respiratory infection is bacterial or viral. (Nine) Auto news: Rare high performance car ...